• Mandatory testosterone deficiency screenings introduced for military personnel aged 30 and older.
• Service members under 30 can voluntarily request testing, with therapy offered if needed.
• The initiative aims to optimize readiness and address health issues linked to low testosterone levels.
• Critics express concerns over the implications and justification of the screenings.
• The policy aligns with broader efforts to ease access to testosterone therapy for men in the U.S.

In an announcement made on Wednesday, Defense Secretary Pete Hegseth stated that the Pentagon will introduce mandatory annual screenings for testosterone deficiency for all service members aged 30 and older. For those under 30, participation will be voluntary. Hegseth emphasized that this initiative is designed to ensure troops can "operate at their absolute best" and maintain their overall health throughout their careers, underscoring the importance of regular medical care, especially regarding hormonal health, according to CBS News, LA Times, and BBC.

As part of the new program, troops diagnosed with low testosterone levels will be offered voluntary testosterone replacement therapy, which Hegseth insists is not about enhancing performance artificially. The program is part of a broader shift towards addressing the health needs of military personnel who may suffer from the effects of low testosterone, which can include decreased strength and mood changes. Research has shown that military training and high operational stress may negatively impact testosterone levels, a concern particularly noted within special operations forces, as outlined by medical professionals, according to LA Times and BBC.

The initiative has been met with scrutiny from various representatives in Congress, as some argue for equal access to similar health screenings and support for women in the military. Rep. Chrissy Houlahan (D-Pa.) expressed hope that testing would extend to female service members as well. Additionally, experts have called for caution regarding the administration of testosterone, indicating it should only be prescribed to individuals showing relevant symptoms and documented low testosterone levels, emphasizing the potential risks associated with such therapy, according to CBS News, LA Times, and BBC.

This policy aligns with recent moves within the Trump administration and the FDA to expand access to testosterone therapy, illustrating a growing acceptance of hormone treatment among broader segments of the male population as a means to improve health and mitigate age-related conditions. Hegseth's emphasis on ensuring troops have access to necessary medical care reflects ongoing policy changes regarding health care in the military, which have been met with both approval and debate concerning their implications for the service members, according to LA Times and BBC.